Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome
Open Access
- 1 September 2001
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 76 (3) , 511-516
- https://doi.org/10.1016/s0015-0282(01)01937-9
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected WomenJournal of Clinical Endocrinology & Metabolism, 1999
- Diastolic DysfunctionCardiology in Review, 1998
- Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI‐1) activity in lean women with and without the polycystic ovary syndromeClinical Endocrinology, 1996
- Carotid atherosclerosis in women with polycystic ovary syndrome: Initial results from a case-control studyPublished by Elsevier ,1996
- Dyslipidaemia is associated with insulin resistance in women with polycystic ovariesClinical Endocrinology, 1996
- Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1995
- Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndromeMetabolism, 1995
- Obesity, lipids, cardiovascular risk, and androgen excessThe American Journal of Medicine, 1995
- Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndromeDiabetes, 1992
- Polycystic ovary syndrome: lack of hypertension despite profound insulin resistanceJournal of Clinical Endocrinology & Metabolism, 1992